Follow
Abhishek Ghara
Abhishek Ghara
Acharya & BM Reddy College of Pharmacy
Verified email at acharya.ac.in
Title
Cited by
Cited by
Year
Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a r eview
E Singh, GSP Matada, N Abbas, PS Dhiwar, A Ghara, A Das
Inflammopharmacology 29 (5), 1347-1355, 2021
222021
Molecular docking and molecular dynamic studies: screening of phytochemicals against EGFR, HER2, estrogen and NF-KB receptors for their potential use in breast cancer
SVB Gurubasavaraj Swamy Purawarga Matada, Prasad Sanjay Dhiwar, Nahid Abbas ...
Journal of Biomolecular Structure and Dynamics, 2021
22*2021
DDR1 and DDR2: a review on signaling pathway and small molecule inhibitors as an anticancer agent
PSDAG Gurubasavaraja Swamy Purawarga Matada, Arka Das
Medicinal Chemistry Research 30 (3), 535-551, 2021
222021
Pharmacophore modeling, virtual screening, molecular docking and dynamics studies for the discovery of HER2-tyrosine kinase inhibitors: An in-silico approach
GSP Matada, PS Dhiwar, N Abbas, E Singh, A Ghara, R Patil, ...
Journal of Molecular Structure 1257, 132531, 2022
102022
An assessment of EGFR and HER2 inhibitors with structure activity relationship of fused pyrimidine derivatives for breast cancer: a brief review
PS Dhiwar, GS Purawarga Matada, R Pal, E Singh, A Ghara, L Maji, ...
Journal of Biomolecular Structure and Dynamics 42 (3), 1564-1581, 2024
72024
Discovery of potential Aurora-A kinase inhibitors by 3D QSAR pharmacophore modeling, virtual screening, docking, and MD simulation studies
G Swamy PM, N Abbas, PS Dhiwar, E Singh, A Ghara, A Das
Journal of Biomolecular Structure and Dynamics 41 (1), 125-146, 2023
72023
An updated literature on BRAF inhibitors (2018–2023)
L Maji, G Teli, NM Raghavendra, S Sengupta, R Pal, A Ghara, ...
Molecular Diversity, 1-42, 2023
42023
Current updates on EGFR and HER2 tyrosine kinase inhibitors for the breast cancer
PS Dhiwar, GSP Matada, NM Raghavendra, A Ghara, E Singh, N Abbas, ...
Medicinal Chemistry Research 31 (9), 1401-1413, 2022
42022
Molecular recognition of some novel mTOR kinase inhibitors to develop anticancer leads by drug-likeness, molecular docking and molecular dynamics based virtual screening strategy
A Das, GSP Matada, PS Dhiwar, NM Raghavendra, N Abbas, E Singh, ...
Computational Toxicology 25, 100257, 2023
32023
A detailed study of Transition Metal Complexes of a Schiff base with its Physico-chemical properties by using an electrochemical method
A Ghara
Asian Journal of Pharmacy and Pharmacology 3 (3), 86-94, 2017
2*2017
Design and Synthesis of Tri-substituted Imidazole Derivatives as CD73 Inhibitors for Their Anticancer Activity
A Ghara, GS Andhale, GSP Matada, PS Dhiwar
Letters in Drug Design & Discovery 19 (3), 242-255, 2022
2022
Design and Synthesis of Tri-substituted Imidazole Derivatives as CD73 Inhibitors for Their Anticancer Activity
AG Ganesh Sakharam Andhale, Gurubasavaraja Swamy Purawarga Matada, Prasad ...
Letters in Drug Design & Discovery, ISSN (Print): 1570-1808, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–12